Radionuclide therapy of malignant bone lesions
Crossref DOI link: https://doi.org/10.1007/s00259-016-3574-3
Published Online: 2016-12-09
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fischer, M.
Biersack, H. J.
Funding for this research was provided by:
IBA Molecular, CISbio GmbH
Amgen, Bayer, GE Healthcare
Tasly (Hong Kong), Shanghai, China
License valid from 2016-12-09